Search Results - "pharmaceuticals"
Suggested Topics within your search.
Suggested Topics within your search.
- Drugs 195
- Pharmaceutical industry 150
- Pharmaceutical chemistry 116
- Drug development 62
- Pharmaceutical technology 52
- Design 48
- Pharmaceutical policy 48
- Pharmaceutical biotechnology 42
- Research 40
- Medicine 39
- Biotechnology 36
- Drug delivery systems 28
- Analysis 26
- Economic aspects 26
- Pharmacology 26
- Pharmacy 26
- Medicine & Public Health 24
- Standards 24
- Therapeutic use 24
- Internal Medicine 22
- Medical policy 22
- Internal medicine 20
- Medical care 20
- Quality control 20
- Biotechnology industries 16
- Safety measures 16
- Technological innovations 16
- Pharmacopoeias 15
- Diseases 14
- Enzymes 14
-
661
Molecules nucleation, aggregation and crystallization : beyond medical and other implications /
Published 2009Table of Contents: “…Chayen -- Introduction to crystallization of fine chemicals and pharmaceuticals / Åke C. Rasmuson -- Myelin basic protein, a saucy molecule with high responsiveness to the environment or just an unusual membrane protein? …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
662
Molecules nucleation, aggregation and crystallization : beyond medical and other implications /
Published 2009Table of Contents: “…Chayen -- Introduction to crystallization of fine chemicals and pharmaceuticals / Åke C. Rasmuson -- Myelin basic protein, a saucy molecule with high responsiveness to the environment or just an unusual membrane protein? …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
663
Statistical issues in drug development
Published 2007Table of Contents: “…A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information --…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
664
Peripheral neuropathies in clinical practice
Published 2010Table of Contents: “…Basic concepts and glossary of common clinical terms -- Anatomic classification of peripheral nervous system disorders -- Evaluation and management of the patient with peripheral neuropathy -- Electrodiagnostic, imaging, nerve, and skin biopsy investigations in peripheral nerve diseases -- Case presentations illustrating the diagnostic method -- Acute immune-mediated neuropathies -- Chronic immune-mediated neuropathies -- Neuropathies associated with monoclonal gammopathies and cancer -- Infectious and granulomatous neuropathies -- Diabetic and other endocrine neuropathies -- Neuropathies associated with vitamin and essential mineral deficiencies and malabsorption -- Vascular/ischemic neuropathies -- Neuropathies associated with organ failure -- The hereditary neuropathies -- Hereditary metabolic/multisystem disorders with neuropathy -- The toxic neuropathy : principles of general and peripheral neurotoxicology; pharmaceutical agents -- The toxic neuropathies : industrial, occupational, and environmental agents -- Focal neuropathies : nerve injuries, entrapments, and other mononeuropathies -- Plexopathies -- Disorders of peripheral nerve hyperexcitability.…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
665
Peripheral neuropathies in clinical practice
Published 2010Table of Contents: “…Basic concepts and glossary of common clinical terms -- Anatomic classification of peripheral nervous system disorders -- Evaluation and management of the patient with peripheral neuropathy -- Electrodiagnostic, imaging, nerve, and skin biopsy investigations in peripheral nerve diseases -- Case presentations illustrating the diagnostic method -- Acute immune-mediated neuropathies -- Chronic immune-mediated neuropathies -- Neuropathies associated with monoclonal gammopathies and cancer -- Infectious and granulomatous neuropathies -- Diabetic and other endocrine neuropathies -- Neuropathies associated with vitamin and essential mineral deficiencies and malabsorption -- Vascular/ischemic neuropathies -- Neuropathies associated with organ failure -- The hereditary neuropathies -- Hereditary metabolic/multisystem disorders with neuropathy -- The toxic neuropathy : principles of general and peripheral neurotoxicology; pharmaceutical agents -- The toxic neuropathies : industrial, occupational, and environmental agents -- Focal neuropathies : nerve injuries, entrapments, and other mononeuropathies -- Plexopathies -- Disorders of peripheral nerve hyperexcitability.…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
666
Statistical issues in drug development
Published 2007Table of Contents: “…A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information --…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
667
Formulation and analytical development for low-dose oral drug products
Published 2009Table of Contents: “….] -- Function, quality, and regulations of pharmaceutical excipients for oral solid dosage forms / Jack Y. …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
668
Plant bioactives and drug discovery principles, practice, and perspectives /
Published 2012Table of Contents: “….] -- Medicinal plants and pharmaceutical technology / Ruth M. Lucinda da Silva, Angélica G. …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
669
Plant bioactives and drug discovery principles, practice, and perspectives /
Published 2012Table of Contents: “….] -- Medicinal plants and pharmaceutical technology / Ruth M. Lucinda da Silva, Angélica G. …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
670
Formulation and analytical development for low-dose oral drug products
Published 2009Table of Contents: “….] -- Function, quality, and regulations of pharmaceutical excipients for oral solid dosage forms / Jack Y. …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
671
-
672
-
673
Label-free biosensors techniques and applications /
Published 2009Table of Contents: “…Cooper -- Application of SPR technology to pharmaceutical relevant drug-receptor interactions / Walter Huber -- High-throughput analysis of biomolecular interactions and cellular responses with resonant waveguide grating biosensors / Ye Fang ... …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
674
Label-free biosensors techniques and applications /
Published 2009Table of Contents: “…Cooper -- Application of SPR technology to pharmaceutical relevant drug-receptor interactions / Walter Huber -- High-throughput analysis of biomolecular interactions and cellular responses with resonant waveguide grating biosensors / Ye Fang ... …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
675
Changing the U.S. health care system : key issues in health services policy and management /
Published 2014Table of Contents: “…Changing the U.S. health care system: the patient protection and affordable care act -- Improving access to care in America -- Ethnic disparities in health status -- Racial and ethnic disparities in health care -- Multilevel social determinants of health -- Public policies to extend health care coverage -- Private health insurance -- Measuring health care costs and trends -- Containing health care costs -- Promoting pharmaceutical access while controlling prices and expenditures -- Measuring health-related quality of life and other outcomes -- Evaluating the quality of care -- Public release of information on quality -- Health care information systems -- Performance measurement of nursing care -- Long-term services and supports for the elderly population -- Hiv and aids in the twenty-first century -- Health reform for children and families -- Homeless persons -- Changing the US health care delivery system -- Medicare reform -- Public health and clinical care -- Strengthening the safety net -- Ethical issues in public health and health services.…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
676
Changing the U.S. health care system : key issues in health services policy and management /
Published 2014Table of Contents: “…Changing the U.S. health care system: the patient protection and affordable care act -- Improving access to care in America -- Ethnic disparities in health status -- Racial and ethnic disparities in health care -- Multilevel social determinants of health -- Public policies to extend health care coverage -- Private health insurance -- Measuring health care costs and trends -- Containing health care costs -- Promoting pharmaceutical access while controlling prices and expenditures -- Measuring health-related quality of life and other outcomes -- Evaluating the quality of care -- Public release of information on quality -- Health care information systems -- Performance measurement of nursing care -- Long-term services and supports for the elderly population -- Hiv and aids in the twenty-first century -- Health reform for children and families -- Homeless persons -- Changing the US health care delivery system -- Medicare reform -- Public health and clinical care -- Strengthening the safety net -- Ethical issues in public health and health services.…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
677
-
678
Defending the brand aggressive strategies for protecting your brand in the online arena /
Published 2004Table of Contents: “…-- What to do -- The business case -- Boardroom summary -- The opportunities and threats of online commentary -- The rumor mill -- Financial earnings -- Early warning -- Information security -- Other security and liability threats -- The world's largest focus group -- Activism and "sucks" sites -- Nobody is immune -- Managing risk -- Buried treasure -- The business case -- Boardroom summary -- Customer diversion -- Customer capture -- Cybersquatting -- Typo-piracy -- Domain name administration -- Arbitration -- Search engine manipulation -- Invisible seeding -- Visible seeding -- Spoofing --Paid placement -- Managing seeding and spoofing issues -- Software utility generated advertisements -- Mislabeled links -- Unsolicited e-mail -- Keeping the customer -- Bringing the customer back -- Scope of the problem -- The future -- The business case -- Boardroom summary -- Online partners and distribution issues -- A managing partner compliance -- The customer experience -- Changing dynamics -- Online partners -- Affiliates -- Suppliers -- Distributors -- Third parties -- Monitoring partners -- Step 1: Prioritization -- Step 2: Brand management -- Step 3: Enforcement -- The business case -- Boardroom summary -- Counterfeits and gray markets -- Gray markets -- Combating gray market activity -- Counterfeiting -- Copier supplies -- Pharmaceuticals -- Online monitoring -- Criteria that may signal a suspect distributor -- Testing authenticity -- The business case -- Boardroom summary -- Defending against digital piracy -- Music -- Sales leads -- Video -- Cease and desist -- Customer convenience -- Copy protection and digital rights management -- Software -- Text and images -- E-books -- The Stephen King experiment -- News services -- Market data -- The business case -- Boardroom summary -- Trust -- The costs of compromised privacy and security -- Information collection technologies -- Cookies -- Web beacons -- Information security -- Customer information transmission -- Customer information storage -- Fraud -- Managing privacy and security -- The business case -- Boardroom summary -- Competitive intelligence -- Using online competitive intelligence to outmaneuver competitor brands -- The internet as a competitive intelligence source -- Brand presence -- Brand reach -- Competitor brand abuse -- Competitor absence -- Linking relationships -- Partnerships -- Recruiting competitor partners -- Online commentary -- Collecting the data -- Counterintelligence -- Actionable information -- The business case -- Boardroom summary.…”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook -
679
-
680